期刊文献+

利托君联合丹参治疗胎儿生长受限疗效观察 被引量:2

Effect of ritodrine hydrochloride combined with radix salviae miltiorrhizae on fetal growth restriction
原文传递
导出
摘要 目的观察盐酸利托君与丹参联合应用治疗胎儿宫内发育迟缓的临床疗效。方法将62例胎儿生长受限孕妇随机分为实验组(n=31)和对照组(n=31),对照组用脂肪乳剂250ml静脉滴注,1次/3d,连用1周;10%葡萄糖注射液500ml+辅酶A100U、三磷酸腺苷40mg、维生素C2g静脉滴注,每日1次;低分子右旋糖酐+复方丹参注射液10ml,静脉滴注,每日1次,共10d。实验组除上述治疗外,再每天加用盐酸利托君100mg静脉滴注,10d为1个疗程。治疗后测量宫高、腹围、体质量及行超声检查了解胎儿的双顶径、头围、腹围、新生儿出生体质量和胎盘重量。结果实验组孕妇的测量指标及新生儿出生体质量和胎盘重量明显高于对照组,差异有统计学意义。结论盐酸利托君联合丹参能改善子宫胎盘血流,促进细胞代谢,改善微循环,促进胎儿生长发育。 Objective Ritodrine hydrochloride(RH) combined with radix salviae miltiorrhiza(RSM) is applied to treat fetal growth ristriction(FGR). Curative effect was recorded during observation. Methods 62 pregnant women with slowly growing fetuses were divided into two groups randomly. Group A(test group) :including 31 pregnant women who received RH combined with RSM treatment, Group B(control group) :including the other 31 pregnant women who only received RSM treatment. Group B received 250ml of fat emulsion injection. One time every three days within one week. At the same time,group B also received injection of 500ml 10 % dextrose, coenzyme A 100U,ATP 40mg,vitamin C 2g,dextran-40 and compound salvia injection 10ml one time a day,ten days in all. Besides the above-mentioned medicament for group B,group A received RH 100ml injection every day. Ten days was a period of treatment. After the treatment, uterine height, abdominal circumference, weight were measured and biparietal diameter, head circumference, abdominal circumference were checked by B-type ultrasonic inspection. After birth,weight of the baby and weight of placenta were measured too. Results Measurement indexes from group A, weight of the new-born baby and weight of placenta are obviously higher than those from group B. Conclusion RH combined with RSM can obviously extend blood vessel, loose placenta, improve blood circulation, accelerate cell metabolism,make microcirculation better, reduce permeability of capillary vessel, keep placenta's function and help foetus' growth.
出处 《中国基层医药》 CAS 2008年第7期1149-1150,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 胎儿生长迟缓 利托君 丹参 药物疗法 联合 Fetal growth retardation Ritodrine Salviae miltiorrhiza Drug therapy,combination
  • 相关文献

参考文献2

  • 1陈孝婉.胎儿宫内发育迟缓//糜若然.妇产科疾病诊断治疗学.北京:人民卫生出版社,2000:140.
  • 2金有豫.药理学.5版.北京:人民卫生出版社,2002:76-77.

共引文献3

同被引文献24

  • 1张明会.胎儿生长受限372例临床分析[J].中国医疗前沿(学术版),2008(5):31-32. 被引量:5
  • 2陈晖.重度妊娠高血压综合征合并胎儿生长受限的围生儿结局分析[J].中国医药,2006,1(5):310-311. 被引量:6
  • 3贾金平.292例胎儿生长受限相关危险因素分析[J].中国基层医药,2006,13(8):1288-1290. 被引量:2
  • 4李扬,黄醒华.胎儿脐动脉血流速度与围产儿预后的关系[J].中华妇产科杂志,1996,31(9):560-561. 被引量:22
  • 5Kim YN, Lee DS, Jeong DH, et al. The relationship of the level of circulating antiangiogenic factors to the clinical manifestations of preeclampsia. Prenat Diagn,2009,20 (5) :464-470.
  • 6Venkatesha S, Toporsian M, Lain C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med, 2006,12 (6) :642-649.
  • 7Staff AC, Braekke K, Johnsen GM, et al. Circulating concentra tions of soluble endoglin( CD105 ) in fetal and maternal serum and in amniotic fluid in preeclampsia. Am J Obstet Gynecol,2007,197 (2) :e1-e6.
  • 8Kanaka-Gantenbein C, Mastorakos G, Chrousos GP. Endocrine-related causes and consequences of intrauterine growth retardation. Ann N Y Acad Sci, 2003, 997:150-157.
  • 9Bischof P, Meisser A, Campana A. Paracrine and autocrine regulators of trophoblast invasion--a review. Placenta,2000,21 Suppl A : 55-60.
  • 10Jeyabalan A, McGonigal S, Gilmour C, et al. Circulating and placental endoglin concentrations in pregnancies complicated by intrauterine growth restriction and preeclampsia. Placenta, 2008,29(6) : 555-563.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部